Skip to main content

Table 4 PAF and direct costs (NIS) attributable to overweight and obesity by diagnoses - Israeli adults (2016)

From: Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel

  PAF overweight PAF obesity Total cost Attributable to overweight & obesity  
Coronary artery disease 16.1% 28.5% 1,055,915,767 470,784,150 21.5%
Diabetes type II 33.5% 56.5% 511,313,763 460,182,387 21.1%
Hypertension 16.8% 30.4% 943,186,656 445,157,136 20.4%
Congestive heart failure 12.1% 24.0% 462,954,791 166,984,682 7.6%
Osteoarthritis 31.1% 35.8% 247,895,278 165,852,084 7.6%
Stroke 8.2% 16.3% 490,337,015 119,962,933 5.5%
Colorectal cancer 18.0% 23.8% 220,788,825 92,322,002 4.2%
Pulmonary embolism 28.2% 48.6% 93,633,779 71,915,718 3.3%
Asthma 8.4% 19.1% 260,546,602 71,698,574 3.3%
Gallbladder disease 9.4% 23.7% 115,622,301 38,181,949 1.7%
Kidney cancer 19.1% 28.5% 46,068,752 21,944,698 1.0%
Pancreatic cancer 10.6% 26.1% 52,536,885 19,257,766 0.9%
Endometrial cancer 16.3% 44.2% 28,576,252 17,298,101 0.8%
Breast cancer 2.8% 4.3% 124,719,472 8,786,692 0.4%
Prostate cancer 6.9% 2.0% 49,259,925 4,358,259 0.2%
Ovarian cancer 6.0% 8.8% 28,750,951 4,263,974 0.2%
Esophageal cancer 5.7% 7.0% 23,724,293 3,015,682 0.1%
Non-alcoholic fatty liver 14.6% 22.4% 4,413,971 1,633,711 0.1%
Gout 31.4% 16.1% 3,409,277 1,618,618 0.1%
Total    6,512,219,714 2,185,219,115 100.0%